<?xml version='1.0' encoding='utf-8'?>
<rss version="2.0">
	<channel>
		<title>OOIR Trends: Clinical Medicine (Integrative &amp; Complementary Medicine)</title>
		<description>Aktuelle Paper-Trends im Bereich Clinical Medicine (Integrative &amp; Complementary Medicine) von OOIR (mit Titel und Metadaten von Crossref)</description>
		<link>https://ooir.org</link>
		<language>en-us</language>
		<pubDate>Mon, 01 Sep 2025 01:12:19 GMT</pubDate>
		<lastBuildDate>Mon, 01 Sep 2025 01:12:19 GMT</lastBuildDate>
		<item>
			<title>Acupuncture for patients with mild cognitive impairment: a randomized, patient–assessor-blinded, sham-controlled pilot study</title>
			<link>https://doi.org/10.1186/s12906-025-05023-5</link>
			<description>Feld: Clinical Medicine
Kategorie: Integrative &amp; Complementary Medicine
Score: 22
Autoren: Yujin Choi, Pyung-Wha Kim, In-Chul Jung, Ae-Ran Kim, Hyo-Ju Park, Ojin Kwon, Jun-Hwan Lee, Joo-Hee Kim
Journal: BMC Complementary Medicine and Therapies
Veröffentlicht: 2025-07-19
Abstract: Abstract
          
            Background
            Mild cognitive impairment (MCI) is the transitional stage between normal aging and early dementia. Although acupuncture is a promising non-pharmacological treatment, higher-quality evidence is needed to confirm its effectiveness.
          
          
            Methods
            A randomized, patient- and assessor-blinded, sham-controlled, pilot clinical trial was conducted to evaluate the feasibility of acupuncture for treating MCI. In total, 30 participants were randomized into acupuncture and sham acupuncture groups. The participants underwent 24 treatment sessions over 12 weeks. The primary outcome was a change in the Alzheimer’s Disease Assessment Scale-Cognitive Subscale (ADAS-cog) score over 12 weeks, whereas the secondary outcomes included the Seoul Neuropsychological Screening Battery (SNSB-II) score. Adverse events and the success of blinding were also assessed.
          
          
            Results
            Of the 30 participants, 28 completed the study. Participants in the acupuncture and sham acupuncture groups exhibited a decrease in ADAS-cog scores from 10.27 ± 4.03 and 11.47 ± 3.85 at baseline to 5.78 ± 3.04 and 6.27 ± 2.83 at week 12, respectively. Both groups exhibited clinically meaningful improvements, with no significant difference between groups (P = 0.6590). The SNSB-II memory domain exhibited a moderate effect size favoring acupuncture (Cohen’s d = 0.57, P = 0.1317). No intervention-related adverse events were reported, and participant blinding was adequate throughout the trial.
          
          
            Conclusions
            The 12-week acupuncture treatment is feasible for patients with MCI and may improve memory. Although the primary outcomes did not reach statistical significance, the secondary outcomes suggested potential benefits. Larger confirmatory trials are warranted to investigate the effectiveness of acupuncture in patients with MCI.
          
          
            Trial registration
            Clinical Research Information Service (cris.nih.go.kr) KCT0001938 (Registered on June 3, 2016).
          
DOI: 10.1186/s12906-025-05023-5
ISSN: 2662-7671
Tag der Erhebung (OOIR): 2025-09-01</description>
			<guid isPermaLink="false">ooir-trend-10.1186/s12906-025-05023-5-2025-09-01-1</guid>
			<pubDate>Sat, 19 Jul 2025 00:00:00 GMT</pubDate>
		</item>
		<item>
			<title>Discovery of pyroptosis-inducing natural products in neuroblastomas: computational studies with experimental validation</title>
			<link>https://doi.org/10.1186/s12906-025-05004-8</link>
			<description>Feld: Clinical Medicine
Kategorie: Integrative &amp; Complementary Medicine
Score: 18
Autoren: Beni Lestari, Rohmad Yudi Utomo, Faaza Aulia Rahman, Dyaningtyas Dewi Pamungkas Putri, Ummi Maryam Zulfin, Yusuke Suenaga, Edy Meiyanto, Yoshitaka Hippo
Journal: BMC Complementary Medicine and Therapies
Veröffentlicht: 2025-07-19
DOI: 10.1186/s12906-025-05004-8
ISSN: 2662-7671
Tag der Erhebung (OOIR): 2025-09-01</description>
			<guid isPermaLink="false">ooir-trend-10.1186/s12906-025-05004-8-2025-09-01-2</guid>
			<pubDate>Sat, 19 Jul 2025 00:00:00 GMT</pubDate>
		</item>
		<item>
			<title>Potential clinical relevance of Buchholzia coriacea: in vitro antimicrobial characteristics of the methanol leaf extract</title>
			<link>https://doi.org/10.1186/s12906-025-05057-9</link>
			<description>Feld: Clinical Medicine
Kategorie: Integrative &amp; Complementary Medicine
Score: 18
Autoren: Xiyao Feng, Chinonyerem O. Iheanacho
Journal: BMC Complementary Medicine and Therapies
Veröffentlicht: 2025-08-19
DOI: 10.1186/s12906-025-05057-9
ISSN: 2662-7671
Tag der Erhebung (OOIR): 2025-09-01</description>
			<guid isPermaLink="false">ooir-trend-10.1186/s12906-025-05057-9-2025-09-01-3</guid>
			<pubDate>Tue, 19 Aug 2025 00:00:00 GMT</pubDate>
		</item>
		<item>
			<title>Trends and patterns of complementary and alternative medicine use among cancer patients in Jordan: a decade comparison</title>
			<link>https://doi.org/10.1186/s12906-025-05065-9</link>
			<description>Feld: Clinical Medicine
Kategorie: Integrative &amp; Complementary Medicine
Score: 18
Autoren: Nedal Al-Rawashdeh, Mohammad Alqudimat, Ibrahim Alananzeh, Nour Kasasbeh, Khawlah Ammar, Amal Al-Omari
Journal: BMC Complementary Medicine and Therapies
Veröffentlicht: 2025-08-26
DOI: 10.1186/s12906-025-05065-9
ISSN: 2662-7671
Tag der Erhebung (OOIR): 2025-09-01</description>
			<guid isPermaLink="false">ooir-trend-10.1186/s12906-025-05065-9-2025-09-01-4</guid>
			<pubDate>Tue, 26 Aug 2025 00:00:00 GMT</pubDate>
		</item>
		<item>
			<title>Inhibitory effects of the flavonoids extracted from Pollen Typhae on palmitic acid-induced NLRP3 inflammasome activation in macrophages involving AMPK-mediated lipid metabolism</title>
			<link>https://doi.org/10.1186/s12906-025-05024-4</link>
			<description>Feld: Clinical Medicine
Kategorie: Integrative &amp; Complementary Medicine
Score: 15
Autoren: Wei Ren, Yushan Yang, Huiming Duan, Wei Nong, Aihua Tang, Hongsheng Lin, Lu Li, Chunling Wang, Xiaotao Feng
Journal: BMC Complementary Medicine and Therapies
Veröffentlicht: 2025-08-28
DOI: 10.1186/s12906-025-05024-4
ISSN: 2662-7671
Tag der Erhebung (OOIR): 2025-09-01</description>
			<guid isPermaLink="false">ooir-trend-10.1186/s12906-025-05024-4-2025-09-01-5</guid>
			<pubDate>Thu, 28 Aug 2025 00:00:00 GMT</pubDate>
		</item>
	</channel>
</rss>